₹ 2,710.00
170.40 (6.71%)
G
GlaxoSmithKline Pharmaceuticals
₹ 2,710.00
GlaxoSmithKline Pharmaceuticals Fundamentals
Company Valuation
Market Cap (₹ Cr.)
45,909
PE Ratio
37.50
PB Ratio
22.87
Dividend Yield
2.24%
ROE
45.69%
ROCE
55.36%
Book Value (₹)
111.04
Face Value (₹)
10.00
Analyse GLAXO with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Domestic Institutional Investors (DII) | 7.75% | 7.70% | 7.68% | 7.80% | 8.48% |
| Foreign Institutional Investors (FII) | 4.80% | 4.64% | 4.62% | 4.79% | 4.75% |
| Public Investors | 10.34% | 10.36% | 10.35% | 10.21% | 9.65% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GLAXO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Midcap
BSE Scrip Code
500660
NSE Scrip Name
GLAXO
ISIN
INE159A01016
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






